8-KEarnings & ResultsExhibits & Filings

Elevance Health, Inc. 8-K Report, Financial Results (Jan 27, 2021)

Filed January 27, 2021For Securities:ELV

Summary

Elevance Health, Inc. (formerly Anthem, Inc.) filed this 8-K on January 27, 2021, to report its financial results for the quarter ended December 31, 2020. The primary purpose of the filing is to furnish a press release detailing these results, which are incorporated by reference. This report primarily serves to disseminate timely financial information to investors and the market. Investors should note that the information furnished in this filing is not considered 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934, nor is it automatically incorporated into future SEC filings unless specifically referenced. The document also includes standard forward-looking statements, cautioning investors about risks and uncertainties that could materially affect actual results, including potential impacts from the COVID-19 pandemic, regulatory changes, healthcare costs, and competitive pressures.

Key Highlights

  • 1The 8-K filing primarily serves to announce and provide access to the company's financial results for the fourth quarter of 2020, released on January 27, 2021.
  • 2The press release containing the detailed financial results for the quarter ended December 31, 2020, is furnished as Exhibit 99.1.
  • 3The filing includes standard cautionary language regarding forward-looking statements, highlighting potential risks and uncertainties.
  • 4Key risks and uncertainties mentioned include the impact of public health emergencies (like COVID-19), healthcare cost trends, regulatory changes (including the ACA), and competitive pressures.
  • 5The company is identified as Anthem, Inc. in this filing, indicating the name change to Elevance Health, Inc. was likely subsequent or this filing predates the official name change announcement.
  • 6No new material events or business updates beyond the financial results announcement are detailed in the 8-K itself.

Frequently Asked Questions

The main purpose of this 8-K filing is to publicly announce and provide access to Elevance Health's (then Anthem, Inc.) financial results for the fourth quarter ended December 31, 2020, through an accompanying press release.

No, the information furnished in Item 2.02 and Exhibit 99.1 of this report is not deemed 'filed' for the purposes of Section 18 of the Securities Exchange Act of 1934. This means it does not carry the same legal implications as information that is officially filed.

The company highlights several risks and uncertainties that could impact future performance. These include the ongoing impact of public health emergencies like COVID-19, fluctuations in healthcare costs and utilization, regulatory changes affecting the healthcare industry (including the ACA), competitive pressures, and potential impacts from litigation or investigations.

While the filing mentions forward-looking statements regarding future operations, products, and performance, the primary focus is on reporting past financial results. Specific future financial guidance or detailed strategic initiatives are not explicitly laid out in the 8-K itself, but would be found within the furnished press release (Exhibit 99.1).